• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

法尼基化和甲基化 KRas4B 与钙调蛋白相互作用的结构基础。

The Structural Basis of the Farnesylated and Methylated KRas4B Interaction with Calmodulin.

机构信息

Computational Structural Biology Section, Basic Science Program, Frederick National Laboratory for Cancer Research, Frederick, MD 21702, USA.

Department of Chemistry, University of Illinois at Chicago, Chicago, IL 60607, USA.

出版信息

Structure. 2019 Nov 5;27(11):1647-1659.e4. doi: 10.1016/j.str.2019.08.009. Epub 2019 Sep 5.

DOI:10.1016/j.str.2019.08.009
PMID:31495533
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8194365/
Abstract

Ca-calmodulin (CaM) extracts KRas4B from the plasma membrane, suggesting that KRas4B/CaM interaction plays a role in regulating Ras signaling. To gain mechanistic insight, we provide a computational model, supported by experimental structural data, of farnesylated/methylated KRas4B interacting with CaM in solution and at anionic membranes including signaling lipids. Due to multiple interaction modes, we observe diverse conformational ensembles of the KRas4B-CaM complex. A highly populated conformation reveals the catalytic domain interacting with the N-lobe and the hypervariable region (HVR) wrapping around the linker with the farnesyl docking to the extended CaM's C-lobe pocket. Alternatively, KRas4B can interact with collapsed CaM with the farnesyl penetrating CaM's center. At anionic membranes, CaM interacts with the catalytic domain with large fluctuations, drawing the HVR. Signaling lipids establishing strong salt bridges with CaM prevent membrane departure. Membrane-interacting KRas4B-CaM complex can productively recruit phosphatidylinositol 3-kinase α (PI3Kα) to the plasma membrane, serving as a coagent in activating PI3Kα/Akt signaling.

摘要

钙调蛋白(CaM)将 KRas4B 从质膜中提取出来,这表明 KRas4B/CaM 相互作用在调节 Ras 信号转导中发挥作用。为了深入了解其机制,我们提供了一个计算模型,该模型得到了实验结构数据的支持,描述了法尼基化/甲基化的 KRas4B 与溶液中和带信号脂质的阴离子膜中的 CaM 相互作用的情况。由于存在多种相互作用模式,我们观察到了 KRas4B-CaM 复合物的多种构象集合。一种高丰度的构象揭示了催化结构域与 N-结构域相互作用,以及超变区(HVR)与连接子缠绕,法尼基与延伸的 CaM 的 C-结构域口袋对接。或者,KRas4B 可以与折叠的 CaM 相互作用,法尼基穿过 CaM 的中心。在阴离子膜上,CaM 与催化结构域之间存在较大的波动,从而拉动 HVR。与 CaM 建立强盐桥的信号脂质可防止膜的脱离。与膜相互作用的 KRas4B-CaM 复合物可以有效地将磷脂酰肌醇 3-激酶 α(PI3Kα)募集到质膜上,作为激活 PI3Kα/Akt 信号的共激活剂。

相似文献

1
The Structural Basis of the Farnesylated and Methylated KRas4B Interaction with Calmodulin.法尼基化和甲基化 KRas4B 与钙调蛋白相互作用的结构基础。
Structure. 2019 Nov 5;27(11):1647-1659.e4. doi: 10.1016/j.str.2019.08.009. Epub 2019 Sep 5.
2
Flexible-body motions of calmodulin and the farnesylated hypervariable region yield a high-affinity interaction enabling K-Ras4B membrane extraction.钙调蛋白的柔性体运动和法尼基化高变区产生高亲和力相互作用,从而实现K-Ras4B的膜提取。
J Biol Chem. 2017 Jul 28;292(30):12544-12559. doi: 10.1074/jbc.M117.785063. Epub 2017 Jun 16.
3
KRAS Prenylation Is Required for Bivalent Binding with Calmodulin in a Nucleotide-Independent Manner.KRAS 异戊烯化以不依赖核苷酸的方式与钙调蛋白形成二价结合是必需的。
Biophys J. 2019 Mar 19;116(6):1049-1063. doi: 10.1016/j.bpj.2019.02.004. Epub 2019 Feb 15.
4
Structural basis of recognition of farnesylated and methylated KRAS4b by PDEδ.PDEδ对法尼基化和甲基化KRAS4b识别的结构基础
Proc Natl Acad Sci U S A. 2016 Nov 1;113(44):E6766-E6775. doi: 10.1073/pnas.1615316113. Epub 2016 Oct 17.
5
Calmodulin disrupts plasma membrane localization of farnesylated KRAS4b by sequestering its lipid moiety.钙调蛋白通过隔离其脂质部分破坏法尼基化 KRAS4b 的质膜定位。
Sci Signal. 2020 Mar 31;13(625):eaaz0344. doi: 10.1126/scisignal.aaz0344.
6
A Non-Canonical Calmodulin Target Motif Comprising a Polybasic Region and Lipidated Terminal Residue Regulates Localization.一种包含多碱性区域和脂化末端残基的非经典钙调蛋白靶标基序调节定位。
Int J Mol Sci. 2020 Apr 15;21(8):2751. doi: 10.3390/ijms21082751.
7
Calmodulin and IQGAP1 activation of PI3Kα and Akt in KRAS, HRAS and NRAS-driven cancers.钙调蛋白和 IQGAP1 激活 KRAS、HRAS 和 NRAS 驱动的癌症中的 PI3Kα 和 Akt。
Biochim Biophys Acta Mol Basis Dis. 2018 Jun;1864(6 Pt B):2304-2314. doi: 10.1016/j.bbadis.2017.10.032. Epub 2017 Oct 31.
8
Organization of Farnesylated, Carboxymethylated KRAS4B on Membranes.膜上法尼基化、羧甲基化 KRAS4B 的组织。
J Mol Biol. 2019 Sep 6;431(19):3706-3717. doi: 10.1016/j.jmb.2019.07.025. Epub 2019 Jul 19.
9
KRas4b-Calmodulin Interaction with Membrane Surfaces: Role of Headgroup, Acyl Chain, and Electrostatics.KRas4b-钙调蛋白与膜表面的相互作用:头部基团、酰基链和静电的作用。
Biochemistry. 2024 Nov 5;63(21):2740-2749. doi: 10.1021/acs.biochem.4c00116. Epub 2024 Oct 9.
10
PIP2 Influences the Conformational Dynamics of Membrane-Bound KRAS4b.PIP2 影响膜结合 KRAS4b 的构象动态。
Biochemistry. 2019 Aug 20;58(33):3537-3545. doi: 10.1021/acs.biochem.9b00395. Epub 2019 Aug 1.

引用本文的文献

1
Distinct Allosteric Networks in CDK4 and CDK6 in the Cell Cycle and in Drug Resistance.细胞周期及耐药性中CDK4和CDK6的不同变构网络
J Mol Biol. 2025 Mar 31:169121. doi: 10.1016/j.jmb.2025.169121.
2
Distinct allosteric networks in CDK4 and CDK6 in the cell cycle and in drug resistance.细胞周期及耐药性中CDK4和CDK6内不同的变构网络
bioRxiv. 2025 Mar 6:2025.02.28.640857. doi: 10.1101/2025.02.28.640857.
3
Pioneer in Molecular Biology: Conformational Ensembles in Molecular Recognition, Allostery, and Cell Function.分子生物学先驱:分子识别、别构效应及细胞功能中的构象集合体
J Mol Biol. 2025 Jun 1;437(11):169044. doi: 10.1016/j.jmb.2025.169044. Epub 2025 Feb 25.
4
KRas4b-Calmodulin Interaction with Membrane Surfaces: Role of Headgroup, Acyl Chain, and Electrostatics.KRas4b-钙调蛋白与膜表面的相互作用:头部基团、酰基链和静电的作用。
Biochemistry. 2024 Nov 5;63(21):2740-2749. doi: 10.1021/acs.biochem.4c00116. Epub 2024 Oct 9.
5
CDK2 and CDK4: Cell Cycle Functions Evolve Distinct, Catalysis-Competent Conformations, Offering Drug Targets.细胞周期蛋白依赖性激酶2和4:细胞周期功能演变为独特的、具有催化活性的构象,提供药物靶点。
JACS Au. 2024 May 14;4(5):1911-1927. doi: 10.1021/jacsau.4c00138. eCollection 2024 May 27.
6
Disruption of Ca/calmodulin:KSR1 interaction lowers ERK activation.阻断 Ca/钙调蛋白与 KSR1 的相互作用可降低 ERK 的激活。
Protein Sci. 2024 May;33(5):e4982. doi: 10.1002/pro.4982.
7
Intrinsically disordered proteins: Ensembles at the limits of Anfinsen's dogma.内在无序蛋白质:处于安芬森法则极限的集合体。
Biophys Rev (Melville). 2022 Mar 17;3(1):011306. doi: 10.1063/5.0080512. eCollection 2022 Mar.
8
Cancer and Autism: How PTEN Mutations Degrade Function at the Membrane and Isoform Expression in the Human Brain.癌症与自闭症:PTEN 突变如何在人类大脑的膜和异构体表达中降低功能。
J Mol Biol. 2023 Dec 15;435(24):168354. doi: 10.1016/j.jmb.2023.168354. Epub 2023 Nov 5.
9
Protein conformational ensembles in function: roles and mechanisms.发挥功能的蛋白质构象集合:作用与机制
RSC Chem Biol. 2023 Sep 5;4(11):850-864. doi: 10.1039/d3cb00114h. eCollection 2023 Nov 1.
10
Higher-order interactions of Bcr-Abl can broaden chronic myeloid leukemia (CML) drug repertoire.Bcr-Abl 的高阶相互作用可以拓宽慢性髓性白血病(CML)的药物谱。
Protein Sci. 2023 Jan;32(1):e4504. doi: 10.1002/pro.4504.

本文引用的文献

1
The structural basis for Ras activation of PI3Kα lipid kinase.Ras 激活 PI3Kα 脂质激酶的结构基础。
Phys Chem Chem Phys. 2019 Jun 5;21(22):12021-12028. doi: 10.1039/c9cp00101h.
2
The mechanism of PI3Kα activation at the atomic level.PI3Kα在原子水平上的激活机制。
Chem Sci. 2019 Feb 20;10(12):3671-3680. doi: 10.1039/c8sc04498h. eCollection 2019 Mar 28.
3
KRAS Prenylation Is Required for Bivalent Binding with Calmodulin in a Nucleotide-Independent Manner.KRAS 异戊烯化以不依赖核苷酸的方式与钙调蛋白形成二价结合是必需的。
Biophys J. 2019 Mar 19;116(6):1049-1063. doi: 10.1016/j.bpj.2019.02.004. Epub 2019 Feb 15.
4
Autoinhibition in Ras effectors Raf, PI3Kα, and RASSF5: a comprehensive review underscoring the challenges in pharmacological intervention.Ras效应器Raf、PI3Kα和RASSF5中的自抑制:一项强调药理学干预挑战的综合综述
Biophys Rev. 2018 Oct;10(5):1263-1282. doi: 10.1007/s12551-018-0461-0. Epub 2018 Sep 29.
5
Allosteric KRas4B Can Modulate SOS1 Fast and Slow Ras Activation Cycles.别构 KRas4B 可以快速和缓慢调节 SOS1 Ras 激活循环。
Biophys J. 2018 Aug 21;115(4):629-641. doi: 10.1016/j.bpj.2018.07.016. Epub 2018 Jul 24.
6
Calmodulin (CaM) Activates PI3Kα by Targeting the "Soft" CaM-Binding Motifs in Both the nSH2 and cSH2 Domains of p85α.钙调蛋白(CaM)通过靶向 p85α 的 nSH2 和 cSH2 结构域中的“软”CaM 结合基序激活 PI3Kα。
J Phys Chem B. 2018 Dec 13;122(49):11137-11146. doi: 10.1021/acs.jpcb.8b05982. Epub 2018 Aug 8.
7
Arl2-Mediated Allosteric Release of Farnesylated KRas4B from Shuttling Factor PDEδ.Arl2 介导的异源二聚化因子 PDEδ 将法尼基化 KRas4B 从穿梭因子上释放。
J Phys Chem B. 2018 Aug 2;122(30):7503-7513. doi: 10.1021/acs.jpcb.8b04347. Epub 2018 Jul 18.
8
K-Ras Populates Conformational States Differently from Its Isoform H-Ras and Oncogenic Mutant K-RasG12D.K-Ras 与它的同工型 H-Ras 和致癌突变体 K-RasG12D 占据不同的构象状态。
Structure. 2018 Jun 5;26(6):810-820.e4. doi: 10.1016/j.str.2018.03.018. Epub 2018 Apr 26.
9
Oncogenic KRas mobility in the membrane and signaling response.致癌性 KRas 在膜中的迁移和信号响应。
Semin Cancer Biol. 2019 Feb;54:109-113. doi: 10.1016/j.semcancer.2018.02.009. Epub 2018 Feb 27.
10
Interaction of Calmodulin with the cSH2 Domain of the p85 Regulatory Subunit.钙调蛋白与p85调节亚基的cSH2结构域的相互作用
Biochemistry. 2018 Mar 27;57(12):1917-1928. doi: 10.1021/acs.biochem.7b01130. Epub 2018 Mar 19.